Predicate |
Object |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-689 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-195 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-205 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-205 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-566 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-577 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-195 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-689 |
filingDate |
2000-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2003-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2003516113-A |
titleOfInvention |
Lawsonia-derived genes and related FlgE polypeptides, peptides and proteins and uses thereof |
abstract |
(57) [Summary]nThe present invention relates generally to therapeutic compositions for the treatment and / or prevention of intestinal disease states in animals and birds caused or flared by Lawsonia intracellularis or similar or other related microorganisms. In particular, the present invention relates to Lawsonia encoding an immunogenic FlgE peptide, polypeptide or protein particularly useful as an antigen in vaccine preparations for conferring humoral immunity against Lawsonia intracellularis and related pathogens in animal hosts.・ Provide novel genes derived from Intracellularis. The present invention also relates to methods for treating and / or preventing such enteric disease states and to diagnostic agents and methods for detecting Lawsonia intracellularis or similar or other related microorganisms. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-4773962-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2007527706-A |
priorityDate |
1999-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |